Stanford Health Care names new COO
Quinn McKenna is responsible for overall operations of the health care system, reporting directly to president and CEO David Entwistle.
15 faculty named CZ Biohub investigators
The researchers will be given funding by the Chan Zuckerberg Biohub to develop tools and technologies that support the organization’s goal of curing, preventing or managing every disease.
Clues to why severe dengue affects some
A new study has found a specific immunologic response among people likely to get severe dengue disease. The work could help lead to a screening test for people at risk of getting a serious case of the disease and to targeted vaccines.
Many breast cancer patients ‘undertested’
Physicians often fail to recommend genetic testing to breast cancer patients at high risk for cancer-associated mutations. Improving access to genetic counseling about the testing process and results is a key priority.
$10.5M in grants for encyclopedia of DNA
Stanford’s William Greenleaf, Michael Bassik, Michael Snyder, Jonathan Pritchard and Michael Cherry have won grants to work on the federally funded Encyclopedia of DNA Elements.
1 cent ‘lab on a chip’
Microfluidics, electronics and inkjet technology underlie a newly developed all-in-one biochip from Stanford that can analyze cells for research and clinical applications.
Circuitry of Parkinson’s revealed
The new Stanford technique probes the neural pathways that cause these tremors, and also provides a way to map and troubleshoot other circuits in the brain.
Scientists awarded stem cell grants
The grants to Stanford researchers target stem cell-based therapies for autoimmune disorders, liver disease and cystic fibrosis.
Spectrum awards $1.74 million in grants
Stanford’s clinical and translational research center has awarded funding to teams of multidisciplinary investigators who are tackling health care problems through novel approaches.
Global health seed grants announced
The Stanford Center for Innovation in Global Health has awarded funding to six multidisciplinary research teams to jump-start novel efforts to address global health challenges.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.